To further validate these results, we assessed BRCA2 isoform expression in an independent cohort of 42 BRCA1/2 mutation-associated primary breast and ovarian tumors (Supplementary Data 1, Supplementary Fig. 11a). This evidence concerns the gene BRCA2 and ovarian neoplasm.